Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 168 participants.

Also called NCT01444248

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 168 participants (enrolled count) (from the registry)
Sponsor
  • Handok Inc. Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01444248
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01444248. Randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2011-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Glimepiride/ Metformin
Intervention (Drug)
Glimepiride/ Metformin
Lead sponsor
Handok Inc. (class: industry)

Record details

Record id
cardio:ct-nct01444248
Content hash
77350ab6ee1e828379c7d9ef53ddf85493b6677020564db02725b8834b9f437d